-
Mashup Score: 1Remaining questions surrounding the use of radiotherapy in SCLC - 1 year(s) ago
Neal Sean McCall, MD, Winship Cancer Institute, Emory University, Atlanta, GA, talks on remaining questions regarding the use of radiation…
Source: VJOncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Sublobar Resection for Small, Early-Stage NSCLC: Establishing a New Standard of Care? - The ASCO Post - 1 year(s) ago
After a nearly 20-year wait, the results are finally in: sublobar surgery has been found to be noninferior to lobectomy and may be the new standard of care of patients with small, early-stage non–small cell lung cancer (NSCLC). Results of the phase III Alliance trial, presented at the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer, showed a…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Chemoimmunotherapy Regimen May Offer Survival Benefit in Subgroups of Metastatic NSCLC - The ASCO Post - 2 year(s) ago
The addition of the CTLA-4 inhibitor tremelimumab to durvalumab and chemotherapy in the first-line setting has already demonstrated an overall survival and progression-free survival benefit vs chemotherapy alone in patients with metastatic non–small cell lung cancer (NSCLC). According to data presented at the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0NELSON vs NLST: Nodule Management Based on Volumetry Shows Increased Benefits - The ASCO Post - 2 year(s) ago
Lung cancer screening has been shown to significantly reduce lung cancer mortality, but some management protocols have more benefit than others, according to data presented at the International Association for the Study of Lung Cancer 2022 World Conference on Lung Cancer (WCLC).1 Although the Dutch-Belgian lung cancer screening trial Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON)…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2IMpower010: Early Survival Data Favor Atezolizumab Over Best Supportive Care in Resected NSCLC With PD-L1 Expression ≥ 50% - The ASCO Post - 2 year(s) ago
Early results from the IMpower010 trial showed an overall survival trend favoring adjuvant atezolizumab vs best supportive care for patients with PD-L1–positive (tumor expression ≥ 1%), stage II–IIIA (UICC/AJCC staging system, 7th ed), resected non–small cell lung cancer (NSCLC). These data were presented at the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1NADIM Trial: Neoadjuvant Chemoimmunotherapy Improved Survival in Resectable, Stage IIIA NSCLC - The ASCO Post - 2 year(s) ago
In patients with resectable, stage IIIA non–small cell lung cancer (NSCLC), the addition of neoadjuvant nivolumab to platinum-based chemotherapy significantly improved overall survival compared with neoadjuvant chemotherapy alone, according to data presented by Mariano Provencio, MD, PhD, at the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Real-World Experience With Durvalumab at the Mayo Clinic Mirrors PACIFIC Findings - The ASCO Post - 2 year(s) ago
By Caroline Helwick Posted: 9/19/2022 10:18:00 AM Last Updated: 9/19/2022 1:45:15 PM Concurrent chemoradiation followed by durvalumab has become the standard of care in patients with unresectable, locally advanced non–small cell lung cancer (NSCLC), based on the PACIFIC trial.1 But clinical trials have…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1High-Intensity Intervention Helps One-Third of Participants in Lung Cancer Screening Program Quit Smoking - The ASCO Post - 2 year(s) ago
By Chase Doyle Posted: 9/15/2022 12:17:00 PM Last Updated: 9/15/2022 12:17:07 PM Despite significant advancements in cancer therapy, a primary means to avoid lung cancer is prevention, and smoking cessation is the most basic intervention. Unfortunately, for long-term smokers, that intervention can sometimes…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Improving Survival in Lung Cancer Starts With Better Screening - 2 year(s) ago
Positive trends in screening of patients at high risk of lung cancer may double survival in this malignancy, according to Giorgio V. Scagliotti, MD, PhD, at 2022 WCLC.
Source: Cancer NetworkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Sexual dysfunction common among women with lung cancer - 2 year(s) ago
Most women with lung cancer reported some degree of sexual dysfunction following diagnosis, according to study results presented during International Association for the Study of Lung Cancer World Conference on Lung Cancer. The findings of the cross-sectional, international Sexual Health Assessment in Women with Lung Cancer (SHAWL) survey study suggested the need for sexual health to be
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
And speaking of Dr. McCall, here he is at the @IASLC #WCLC2022 https://t.co/2bHTEuidOq